What Happened?
Boston, MA-based Inozyme Appointed Gayle Gironda as Senior Vice President of Human Resources
About the Company
We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.
About the Person
Gayle T. Gironda is Senior Vice President of Human Resources at Inozyme. Previously, Gayle held various senior HR leadership roles in the industry.
Info Source
News
Short Profile